2013

1. Comparative effects of teriparatide and risedronate in glucocorticoid- induced osteoporosis in men: 18-month results of the EuroGIOPs trial

   Journal of Bone and Mineral Research, Vol. 28, Núm. 6, pp. 1355-1368

2. Early changes in biochemical markers of bone formation during teriparatide therapy correlate with improvements in vertebral strength in men with glucocorticoid-induced osteoporosis

   Osteoporosis International, Vol. 24, Núm. 12, pp. 2971-2981